Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Short Interest Down 6.3% in November
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) saw a large decline in short interest in November. As of November 15th, there was short interest totalling 6,500,000 shares, a decline of 6.3% from the October 31st total of 6,940,000 shares. Based on an average daily trading volume, of 713,900 shares, the days-to-cover ratio is presently […]
More Stories
Verition Fund Management LLC Reduces Position in SITE Centers Corp. (NYSE:SITC)
Verition Fund Management LLC decreased its position in SITE Centers Corp. (NYSE:SITC – Free Report) by 9.8% during the 3rd...
Verition Fund Management LLC Takes Position in Ares Capital Co. (NASDAQ:ARCC)
Verition Fund Management LLC bought a new position in shares of Ares Capital Co. (NASDAQ:ARCC – Free Report) during the...
Rand Capital Corporation Declares Dividend of $4.20 per Share.
On December 5, 2024, Rand Capital Corporation (NASDAQ: RAND) announced that its Board of Directors approved a dividend on the...
Flow Traders U.S. LLC Makes New Investment in B2Gold Corp. (NYSE:BTG)
Flow Traders U.S. LLC purchased a new stake in shares of B2Gold Corp. (NYSE:BTG – Free Report) during the 3rd...
Veeco Instruments (NASDAQ: VECO) Faces New Regulatory Challenge with 2024 BIS Rules
Veeco Instruments Inc., a Delaware-based company specializing in advanced thin film process technologies, recently disclosed in a Form 8-K filing...
Edgestream Partners L.P. Sells 137,472 Shares of Clearway Energy, Inc. (NYSE:CWEN)
Edgestream Partners L.P. decreased its holdings in Clearway Energy, Inc. (NYSE:CWEN – Free Report) by 93.2% during the third quarter,...